Evren Technologies announces appointment of Robert V. House, Ph.D., as new director
Gainesville, FL June 1, 2021 –
Evren Technologies, Inc. announced today that Robert V. House, PhD, has been appointed to the Board of Directors. “We are pleased to welcome Dr. House and know he will be an outstanding addition to our Board of Directors,” said Weaver H. Gaines, Executive Chairman of the Board of Directors. “With Robert’s knowledge and extensive background in government contracts, he will greatly assist the Company in applying for and obtaining non-dilutive funding for our research and development of products to assist the Department of Defense in Warfighter resilience and coping with combat stressors.”
Dr. House is an independent consultant and was previously Senior Vice President, Government Contracts of Ology Bioservices, responsible for managing and leading the contract management and oversight process of major US Government contracts with various agencies including the DoD, NIH, HHS, and other federal entities. He is also a director of Arrevus, Inc. and an adjunct professor at George Mason University. Dr. House is a graduate of the University of North Carolina at Chapel Hill, where he received his BA, his MS in Public Health, and his PhD.
About Evren Technologies
Evren Technologies is a clinical stage bioelectronic medicine company advancing the treatment of PTSD by delivering cutting edge Vagal Nerve Stimulation (VNS) technology through a user-friendly and intelligent hardware and software platform that is easy to use and personalized. Our initial medical device - the Phoenix® - will deliver transcutaneous auricular vagal nerve stimulation (taVNS) in a discreet earbud design. Pairing the Phoenix with our PTSD symptom tracking app will allow for reimbursable remote clinician monitoring and the establishment of a leading PTSD database that collects biosignals, symptom tracking, triggering events, and therapy effectiveness.